Mechanism of Action: Dihydroorotate Dehydrogenase Inhibitors
✉ Email this page to a colleague
Drugs with Mechanism of Action: Dihydroorotate Dehydrogenase Inhibitors
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Natco | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209555-001 | May 15, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Msn | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209623-002 | Apr 24, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Aurobindo Pharma | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209638-002 | Oct 26, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |